Revenio Group Oyj (OTCMKTS:REVXF – Get Free Report) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 12,217 shares, a growth of 5,530.0% from the May 14th total of 217 shares. Based on an average daily volume of 430 shares, the short-interest ratio is currently 28.4 days.
Revenio Group Oyj Stock Performance
OTCMKTS:REVXF opened at $16.41 on Wednesday. Revenio Group Oyj has a fifty-two week low of $16.41 and a fifty-two week high of $16.54. The business’s 50-day simple moving average is $18.40 and its 200-day simple moving average is $21.35.
About Revenio Group Oyj
Revenio Group Oyj is a Finland‐based medical technology company specializing in ophthalmic diagnostic instruments. The company’s core business centers on the design, manufacture and sales of intraocular pressure (IOP) measurement devices that support glaucoma screening, diagnosis and long‐term patient monitoring. Utilizing patented rebound tonometry technology, Revenio’s tonometers provide rapid, non-invasive IOP readings without the need for topical anesthesia, making them well‐suited for both clinical and home settings.
Revenio’s product portfolio is anchored by the Icare® family of tonometers, which includes the Icare PRO for clinical use and the Icare HOME for patient self-monitoring.
Further Reading
- Five stocks we like better than Revenio Group Oyj
- Synchrony’s Comeback Is Hiding in Plain Sight
- Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand
- Optical Cable Corporation: Strong Earnings, But Hurdles Remain
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
Receive News & Ratings for Revenio Group Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revenio Group Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
